This report provides a causal mechanism by which obesity promotes breast cancer progression and lays out a foundation to block NLRC4 inflammasome activation or IL-1β signalling transduction that may be useful for the treatment of obese cancer patients. This evidence concerns the gene NLRC4 and obesity due to melanocortin 4 receptor deficiency.